Cost effectiveness of statins: are the differences really important?

    loading  Checking for direct PDF access through Ovid

Abstract

With the clinical effectiveness of HMG CoA reductase inhibitors [statins] now well-established, pharmaceutical companies' thoughts increasingly turn to highlighting differences within the class - clinical, pharmacological and economical. Several studies presented at meetings over the last few months suggest that some newer statins are more cost effective than older members of the class. Nevertheless, a recent paper emphasises that, for primary prevention at least, the issues preventing wider statin prescribing may be more fundamental than relatively minor differences in cost effectiveness.

Related Topics

    loading  Loading Related Articles